Navigation Links
Lucas Bagnell Varga LLC Secures $17.4 Million Award For Former Applied Biosystems Executives
Date:12/6/2012

SOUTHPORT, Conn., Dec. 6, 2012 /PRNewswire/ --  A three-member panel of the American Abritration Association today awarded former executives of Applied Biosystems, Inc., f/k/a Perkin Elmer Corporation, $17.4 million in unpaid change in control benefits from Life Technologies Corporation, one of the world's largest biotechnology companies. (NASDAQ:   LIFE).  The case was presented to a former federal judge, former state judge and a senior member of the Connecticut Bar over a period of two years.  According to the claim of the executives, the incentive compensation became due from Life Technologies Corporation when it assumed the obligations of the executives' employment agreements after acquiring Applied Biosystems, Inc. in November 2008.  Life Technologies argued the executives were misreading their agreements and were not entitled to continued stock-based benefit awards.   

In finding for the executives, the arbitration Panel held the agreements were breached as "the Company made no effort to provide [the claimed benefits], and the Claimants are entitled to them."  "We are very pleased with the outcome, and are happy our clients will finally receive these sums which they earned and are long overdue," said Scott Lucas, lead trial counsel for the executives.  "Consultants from Citrin Cooperman were instrumental in helping us present our clients' complex damages claim to the Panel," added Jeff Bagnell, who handled the damages aspect of the case at trial. 

The executives were represented by Lucas Bagnell Varga LLC in Southport, Connecticut.  Life Technologies was represented by DLA Piper.

Media Contact:
Jeff Bagnell
1-203-227-8400
jbagnell@lbv-law.com


'/>"/>
SOURCE Lucas Bagnell Varga LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies
2. A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for Clinical Tests and at the Same Time Secures Substantial Financing
3. Roka Bioscience Secures $47.5 Million in Series D Financing
4. Generex Secures Commitments for $3.6M Capital Raise
5. PharmAthene Secures $7.5 Million Credit Facility From GE Capital, Healthcare Financial Services
6. Insmed Secures $20 Million Loan Agreement With Hercules Technology Growth Capital
7. Bacterin Secures $25 Million Financing with OrbiMed
8. OncoSec Secures License for Electroporation Intellectual Property from University of South Florida
9. Aviir Diagnostic Laboratories Secures $8 Million In Funding From Silicon Valley Bank
10. Syngenta Secures EU Approval For Next Generation Fungicide
11. Amarantus BioSciences Secures $1.1 Million in Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016 AskLinkerReports.com has published a report ... Amyloglucosidase Industry 2016 Market Research Report. From a basic outline ... overview are all covered in the report. This report projects ... analysis of the Amyloglucosidase industry. ... , , ...
(Date:12/8/2016)... , Dec. 8, 2016  Renova™ Therapeutics, ... congestive heart failure and type 2 diabetes, announced ... a novel adeno-associated virus (AAV) vector developed in ... M.D., Ph.D., at Stanford University. The company plans ... paracrine gene therapy product pipeline. ...
(Date:12/8/2016)... CARDIFF, UK (PRWEB) , ... December 08, 2016 ... ... high precision light to control cells — optogenetics — is key to exciting ... state of the art, spatially patterned light projected via free-space optics stimulates small, ...
(Date:12/8/2016)... 2016 Oxford Gene ... seine Palette an anpassbaren SureSeq™ NGS-Panels mit dem ... das ein schnelles und kostengünstiges Studium der Varianten ... eine Erkennung von Einzel-Nukleotid-Variationen (Single Nucleotide Variation, SNV) ... kleinen Panel und ermöglicht eine individuelle Anpassung durch ...
Breaking Biology Technology:
(Date:12/7/2016)... Dec. 7, 2016   Veridium , a ... appointment of new CEO James Stickland . ... decades of experience, has served in senior executive ... he specialized in expanding a pipeline of venture ... He most recently served as managing director of ...
(Date:12/6/2016)... Securus Technologies, a leading provider of ... safety, investigation, corrections and monitoring, and the Prison ... (5) year funding commitment by Securus to PEP ... and reentry support to more inmates and their ... the Prison Entrepreneurship Program (PEP) is an independent ...
(Date:12/2/2016)...   SoftServe , a global digital technology ... electrocardiogram (ECG) biosensor analysis system for continuous driver ... The smart system ensures device-to-device communication between ECG ... mobile devices to easily ,recognize, and monitor users ... technology advances, so too must the security systems ...
Breaking Biology News(10 mins):